It is clearly demonstrated that TNBC cells strongly induce PSMA in tumor-associated endothelial cells, whereas the expression of PSMA on the TNBC cells alone is most likely not sufficient for [177Lu]Lu-PSMA therapy. The gene discussed is FOLH1; the disease is neoplasm.